Achondrogenesis type 1B

From WikiMD's WELLNESSPEDIA

(Redirected from Fraccaro achondrogenesis)


Achondrogenesis type 1B
File:Autosomal recessive - en.svg
Synonyms Achondrogenesis, Fraccaro type
Pronounce N/A
Specialty N/A
Symptoms Severe dwarfism, short limbs, underdeveloped lungs, hydrops fetalis
Complications N/A
Onset Prenatal
Duration Lifelong
Types N/A
Causes Mutations in the SLC26A2 gene
Risks Genetic inheritance
Diagnosis Ultrasound, genetic testing
Differential diagnosis Thanatophoric dysplasia, osteogenesis imperfecta
Prevention N/A
Treatment Supportive care
Medication N/A
Prognosis Poor, often lethal in neonatal period
Frequency Rare
Deaths N/A


Achondrogenesis type 1B is a rare genetic disorder characterized by severe skeletal dysplasia, which affects the development of bones and cartilage. It is one of the subtypes of achondrogenesis, a group of disorders that result in short stature and other skeletal abnormalities. Achondrogenesis type 1B is inherited in an autosomal recessive pattern.

Genetics[edit]

Achondrogenesis type 1B is caused by mutations in the SLC26A2 gene, which provides instructions for making a protein involved in the development of cartilage and bone. This gene is located on chromosome 5. The mutations lead to a deficiency in the protein's function, resulting in the characteristic skeletal abnormalities of the disorder.

Pathophysiology[edit]

The SLC26A2 protein is essential for the normal development of cartilage, which is a precursor to bone. In achondrogenesis type 1B, the defective protein disrupts the normal process of endochondral ossification, where cartilage is gradually replaced by bone. This disruption leads to the accumulation of cartilage and underdeveloped bones, particularly affecting the spine, ribs, and limbs.

Clinical Features[edit]

Individuals with achondrogenesis type 1B typically present with:

These features are usually evident on prenatal ultrasound and can lead to complications during pregnancy and delivery.

Diagnosis[edit]

Diagnosis of achondrogenesis type 1B is based on clinical features, radiographic findings, and genetic testing. Prenatal ultrasound may reveal characteristic skeletal abnormalities. Genetic testing can confirm mutations in the SLC26A2 gene.

Management[edit]

There is currently no cure for achondrogenesis type 1B. Management focuses on supportive care and addressing complications. Due to the severity of the condition, many affected infants are stillborn or die shortly after birth. Genetic counseling is recommended for affected families.

Related pages[edit]

Gallery[edit]



Achondrogenesis type 1B[edit]